Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
1.780
+0.020 (1.14%)
At close: Dec 20, 2024, 4:00 PM
1.850
+0.070 (3.93%)
After-hours: Dec 20, 2024, 6:37 PM EST
Quince Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 78 | 45 | 23 | 377 | 819 | 1,507 | |
| Market Cap Growth | -17.57% | 95.46% | -93.89% | -53.99% | -45.64% | - | |
| Enterprise Value | 46 | -38 | -71 | 264 | 682 | 1,387 | |
| Last Close Price | 1.78 | 1.05 | 0.64 | 12.62 | 27.78 | 56.14 | |
| PB Ratio | 1.71 | 0.53 | 0.23 | 3.18 | 4.76 | 13.05 | |
| P/TBV Ratio | 0.76 | 11.89 | 0.24 | 3.18 | 4.76 | 13.05 | |
| Debt / Equity Ratio | 0.34 | 0.16 | 0.00 | 0.01 | 0.00 | - | |
| Quick Ratio | 9.00 | 7.95 | 29.71 | 7.59 | 7.87 | 11.23 | |
| Current Ratio | 9.53 | 8.09 | 30.55 | 7.85 | 8.11 | 11.93 | |
| Return on Equity (ROE) | -83.18% | -33.81% | -47.14% | -61.85% | -53.42% | -39.57% | |
| Return on Assets (ROA) | -18.82% | -11.33% | -26.40% | -34.99% | -31.42% | -24.82% | |
| Return on Capital (ROIC) | -27.78% | -15.41% | -28.36% | -38.60% | -34.22% | -26.20% | |
| Earnings Yield | -68.01% | -69.73% | -224.32% | -23.85% | -9.38% | -2.45% | |
| FCF Yield | -39.04% | -40.99% | -191.80% | -16.74% | -6.21% | -2.21% | |
| Buyback Yield / Dilution | -18.71% | -11.17% | -12.71% | -1.86% | -53.30% | -466.06% | |
| Total Shareholder Return | -18.71% | -11.17% | -12.71% | -1.86% | -53.30% | -466.06% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.